亚临床甲减与2型糖尿病患者颈动脉粥样硬化和糖尿病肾脏病的相关性研究
本文关键词:亚临床甲减与2型糖尿病患者颈动脉粥样硬化和糖尿病肾脏病的相关性研究 出处:《山西医科大学》2016年硕士论文 论文类型:学位论文
更多相关文章: 2型糖尿病 亚临床甲状腺功能减退 颈动脉粥样硬化 糖尿病肾脏病
【摘要】:目的:本研究旨在分析亚临床甲状腺功能减退与2型糖尿病患者颈动脉粥样硬化和糖尿病肾脏病的相关性,从而探讨亚临床甲状腺功能减退对2型糖尿病患者血管并发症的影响。方法:连续收集2015年8月至2015年12月间于山西医科大学第一医院内分泌科住院的T2DM患者310例进行横断面研究,其中男性182例,女性128例,平均年龄(59.1±8.8)岁,平均糖尿病病程(9.8±6.6)年,平均体重指数(BMI)(24.77±2.92)kg/m2。所有患者均符合1999年WHO糖尿病诊断分型标准。排除标准:合并有糖尿病急性并发症、感染、妊娠、严重的心肝肾功能不全、恶性肿瘤者,以及既往有甲状腺疾病史,或使用对甲状腺功能有影响的药物者。采集患者的一般资料包括:年龄、性别、糖尿病病程、既往史、吸烟史、记录入院时血压、身高、体重,计算BMI。身高测定:被测者脱去身上较重的衣物、鞋、包等,赤脚以立正姿势站于标准体重计的中部,头摆正,眼睛平视前方,测量精确到0.01m。体重测定:被测者空腹,脱去身上较重的衣物、鞋、包等,身上仅留单衣,赤脚站于标准体重计的中部,测量精确到0.1kg。血压测量:所有患者均于安静的环境中至少休息30分钟(期间禁止抽烟,喝酒,饮用咖啡、茶等饮料),然后用标准水银血压计按照袖带加压法于右上臂进行测量,每人最少测量2次(中间需相隔3分钟),最后取其平均值作为血压的测定值。全部患者均于入院后次日清晨空腹8-12小时后留取肘静脉血,检测指标包括:游离三碘甲状原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺素(TSH)、空腹血糖(FPG)、糖化血红蛋白(hba1c)、总胆固醇(tc)、甘油三酯(tg)、血肌酐(scr)、高密度脂蛋白胆固醇(hdl-c)、低密度脂蛋白胆固醇(ldl-c)、超敏c反应蛋白(hs-crp)、血清天门冬氨酸氨基转移酶(ast)、血清丙氨酸氨基转移酶(alt)。同时留取晨尿检测尿微量白蛋白和尿肌酐,计算尿微量白蛋白和尿肌酐的比值(uacr)。依据scr值计算肾小球滤过率(egfr),采用适于中国人的改良mdrd公式,egfr[ml/(min·1.73m2)]=175×scr-1.234×年龄-0.179(如果是女性×0.79)。所有患者行颈动脉彩超检查来获得内膜中层厚度(imt)和有无斑块的形成,将imt≥1.0mm或合并有明显斑块者定义为颈动脉粥样硬化(cas),imt1.0mm以及管壁光滑者定义为无cas。依据《糖尿病肾病防治专家共识》(2014版)将uacr≥30mg/g或有糖尿病视网膜病合并egfr异常者(egfr90ml/(min·1.73m2))视为糖尿病肾脏病(dkd)。亚临床甲状腺功能减退(sch)参照《成人甲状腺功能减退治疗指南》(2012版)的诊断标准:血清tsh水平高于正常值上限,血清ft3、ft4在正常范围。结合本院甲功的参考范围,以tsh4.2uiu/ml为sch诊断切点,即tsh≥4.2uiu/ml,且ft3、ft4正常者诊断sch。依据甲状腺功能将患者分为2组:单纯t2dm组、t2dm合并sch组。比较两组cas和dkd的差异。logistic回归分析探讨sch与cas和dkd的关系。所有数据用spss20.0统计软件进行分析,计量资料以均数±标准差(x±s)表示,对数据进行正态性检验,偏态分布计量资料如tsh、fpg、tg、tc等应用自然对数转换后再分析,组间比较采用t检验。计数资料以百分率表示,组间比较采用卡方检验。危险因素分析采用logistic回归分析。p0.05表示差异有统计学意义。结果:1.t2dm合并sch组与单纯t2dm组的临床参数比较:与单纯t2dm组相比,t2dm合并sch组的hs-crp水平高、tc水平高、tg水平高,差异有统计学意义(p0.05);两组性别、年龄、bmi、糖尿病病程、高血压病史、吸烟、sbp、dbp、fpg、hba1c、hdl-c、ldl-c相比较,差异无统计学意义(p0.05)。2.t2dm合并sch组与单纯t2dm组cas和dkd发生率的比较:t2dm合并sch组cas和dkd发生率均高于单纯t2dm组,差异有统计学意义(p0.05)。3.T2DM患者CAS的logistic回归分析:3.1单因素logistic回归分析:以有无CAS为因变量,分别以有无SCH、性别、年龄、糖尿病病程、有无高血压、是否吸烟、SBP、DBP、FPG、HbA1c、TC、TG、HDL-C、LDL-C为自变量做单因素logistic回归分析,结果显示:SCH(OR值为2.214,P0.05)、高血压(OR值为2.451,P0.05)、年龄(OR值为1.062,P0.05)、糖尿病病程(OR值为1.054,P0.05)、TC(OR值为1.079,P0.05)与CAS相关。3.2多因素logistic回归分析:以有无CAS为因变量,以单因素分析筛选出的和临床中有共识的指标为自变量做多因素logistic回归分析,结果显示:在调整年龄、性别、糖尿病病程、BMI、高血压、吸烟、TC后,SCH与CAS相关(OR值为2.364,P0.05),SCH患者发生CAS的风险是无SCH患者的2.364倍。4.T2DM患者DKD的logistic回归分析:4.1单因素logistic回归分析:以有无DKD为因变量,分别以有无SCH、性别、年龄、糖尿病病程、有无高血压、是否吸烟、SBP、DBP、FPG、HbA1c、TC、TG、HDL-C、LDL-C为自变量做单因素logistic回归分析,结果显示:SCH(OR值为1.849,P0.05)、高血压(OR值为2.091,P0.05)、SBP(OR值为1.028,P0.05)、HbA1c(OR值为1.272,P0.05)、TG(OR值为1.350,P0.05)与DKD相关。4.2多因素logistic回归分析:以有无DKD为因变量,以单因素分析筛选出的和临床中有共识的指标为自变量做多因素logistic回归分析,结果显示:在调整性别、年龄、糖尿病病程、高血压、BMI、SBP、HbA1c、TG后,SCH与DKD相关(OR值为2.053,P0.05),SCH患者发生DKD的风险是无SCH患者的2.053倍。结论:1.2型糖尿病合并亚临床甲减者颈动脉粥样硬化的发生率增高,亚临床甲减可能会增加2型糖尿病患者颈动脉粥样硬化的发生风险。2.2型糖尿病合并亚临床甲减者糖尿病肾脏病的发生率增高,亚临床甲减可能会增加2型糖尿病患者糖尿病肾脏病的发生风险。
[Abstract]:Objective: the purpose of this study is to analyze the correlation between subclinical hypothyroidism and carotid atherosclerosis and diabetic nephropathy in type 2 diabetic patients, so as to explore the effect of subclinical hypothyroidism on vascular complications in patients with type 2 diabetes. Methods: from August 2015 to December 2015 in 310 cases of T2DM patients hospitalized in the Department of Endocrinology, the first hospital of Shanxi Medical University were investigated, of which 182 were male, 128 were female, the average age (59.1 + 8.8) years old, the average duration of diabetes (9.8 + 6.6) years, the average body mass index (BMI) (24.77 + 2.92) kg/m2. All patients were in accordance with the diagnostic criteria for WHO diabetes in 1999. Exclusion criteria: those with diabetes, acute complications, infection, pregnancy, severe heart, liver and kidney dysfunction, malignant tumor, and past history of thyroid disease, or those who have influence on thyroid function. The general data of the patients included age, sex, course of diabetes, history, history of smoking, history of smoking, blood pressure, height, weight, and BMI. Height determination: measured by removing his heavy clothing, shoes, bags, barefoot in the central station to stand at attention posture, the standard weight of head upright, eyes straight ahead, accurate to 0.01m. Weight determination: measured fasting, removing his heavy clothing, shoes, bags and other body, leaving only unlined, standing barefoot in the central standard weight measurement, accurate to 0.1kg. Blood pressure measurement: all the patients were in a quiet environment to rest for at least 30 minutes (smoke, drink alcohol during prohibition, drinking coffee, tea and other drinks), and then use the standard mercury sphygmomanometer cuff compression method according to the measurement in the right arm, each at least 2 measurements (which requires 3 minutes apart), finally take the average as the blood pressure measurement. All patients were admitted to hospital after fasting for 8-12 hours after leaving the umbilical venous blood, the indexes included: free three iodine thyroid original acid (FT3), free thyroxine (FT4), thyroid stimulating hormone (TSH), fasting blood glucose (FPG), glycosylated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), serum creatinine (SCR), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), high sensitive C reactive protein (hs-CRP), serum aspartate aminotransferase (AST), serum alanine aminotransferase (ALT). The urine microalbuminuria and urinary creatinine were measured at the same time, and the ratio of urine microalbuminuria and urine creatinine (UACR) was calculated. According to the SCR value, we calculated glomerular filtration rate (EGFR) and adopted the modified MDRD formula suitable for Chinese people, egfr[ml/ (min. 1.73m2)]=175 * scr-1.234 * age -0.179 (if female X 0.79). All patients underwent carotid artery ultrasonography to obtain the intima-media thickness (IMT) and plaque formation, IMT = 1.0mm or with obvious plaque were defined as carotid atherosclerosis (CAS), imt1.0mm and the smooth tube wall is defined as cas. On the basis of "expert consensus" prevention and treatment of diabetic nephropathy (2014 Edition) UACR = 30mg/g or diabetic retinopathy with abnormal EGFR (egfr90ml/ (min, 1.73m2)) as diabetic kidney disease (DKD). Subclinical hypothyroidism (SCH) is based on the diagnostic criteria of the treatment guidelines for adult hypothyroidism (2012 Edition): serum TSH level is higher than the upper limit of normal value, serum FT3 and FT4 are in normal range. With the reference range of thyroid function in our hospital, to tsh4.2uiu/ml for the diagnosis of SCH sites, TSH is more than 4.2uiu/ml, FT3, FT4 and sch of normal diagnosis. According to the thyroid function, the patients were divided into 2 groups: simple T2DM group, T2DM combined with Sch group. The differences between the two groups of CAS and DKD were compared. Logistic regression analysis was used to investigate the relationship between Sch and CAS and DKD. All data were analyzed by spss20.0 statistical software. The data were represented by mean + standard deviation (x + s). The normality of data was tested, and the skewed distribution data such as TSH, FPG, TG and TC were re analyzed after natural logarithmic transformation. T test was used in comparison between groups. The count data were expressed as a percentage, and the chi square test was used among the groups. Logistic regression analysis was used for the analysis of risk factors. P0.05 indicated that the difference was statistically significant. Results: compare the clinical parameters of 1.t2dm combined with Sch group and T2DM group: compared with T2DM group, T2DM Sch group with high hs-CRP level, high Tc level, TG level is high, the difference was statistically significant (P0.05); the two groups of gender, age, BMI, duration of diabetes, hypertension, smoking history, SBP FPG, HbA1c, DBP, HDL-C, and LDL-C, the difference was not statistically significant (P0.05). The incidence of CAS and DKD in group 2.t2dm combined with Sch and T2DM alone: the incidence of CAS and DKD in T2DM plus Sch group were all higher than those in simple T2DM group, the difference was statistically significant (P0.05). Patients with 3.T2DM CAS logistic regression analysis: 3.1 single factor Logistic regression analysis: the CAS as the dependent variable, respectively, with no SCH, gender, age, duration of diabetes, hypertension, smoking, no SBP, DBP, FPG, HbA1c, TC, TG, HDL-C and LDL-C as independent variables to do single factor Logistic regression analysis results showed that: SCH (OR = 2.214, P0.05), hypertension (OR = 2.451, P0.05), age (OR = 1.062, P0.05), diabetes (OR = 1.054, P0.05), TC (OR = 1.079, P0.05) and CAS. Logistic 3.2 multi factor regression analysis: with or without CAS as the dependent variable, using single factor analysis results are consensus screened and clinical index for logistic independent multi factor regression analysis showed that after adjusting for age, sex, duration of diabetes, hypertension, smoking, BMI, TC, SCH and CAS (OR = 2.364, P0.05), risk of patients with SCH CAS is 2.364 times higher than in patients without SCH. Logistic regression analysis of DKD in patients with 4.T2DM: 4.1 univariate logistic regression analysis: whether DKD was the dependent variable, whether there were SCH, gender, age, duration of diabetes, hypertension, smoking, SBP, D.
【学位授予单位】:山西医科大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R587.2;R581.2
【相似文献】
相关期刊论文 前10条
1 王玉新,李大启,李公宝,徐琴君;糖尿病肾病患者血清可溶性白细胞介素6受体检测[J];上海免疫学杂志;2001年02期
2 宫雅南,刘冬年,熊玉冰,黄伟文,庄万江;糖尿病足患者糖尿病视网膜病变分析[J];广东医学;2001年06期
3 顾芹,宋守君,李向阳,尤传一;胰激肽原酶肠溶片对早期糖尿病肾病的防治作用[J];中国临床药学杂志;2001年06期
4 曹爱华 ,王瑛 ,李翔;杏丁治疗早期糖尿病肾病疗效观察[J];辽宁实用糖尿病杂志;2001年03期
5 ;中药治疗糖尿病肾病新进展[J];中国中医药信息杂志;2001年04期
6 张桂茹;糖尿病肾病85例临床分析[J];陕西医学杂志;2002年02期
7 侯建明 ,林凤辉 ,张超群;46例2型糖尿病肾病与糖尿病自主神经病变的关系分析[J];福建医药杂志;2002年04期
8 陈文霖;糖尿病饮食[J];医疗保健器具;2002年Z1期
9 孙力,许玲;2型糖尿病患者糖尿病足的危险因素分析[J];山东医药;2002年35期
10 ;糖尿病肾病诊治研究进展[J];基础医学与临床;2003年04期
相关会议论文 前10条
1 张星;许筠;苏建平;张军;程立志;翟晓丽;;糖尿病肾病的临床疗效对比观察[A];第十九次全国中医肾病学术交流会论文汇编[C];2006年
2 杨家茂;;糖尿病肾病防治琐谈[A];全国第二届中医中西医结合肾脏病临床进展学术研讨会论文集[C];2007年
3 丁耀耿;郝桂霞;;糖尿病肾病临床分析[A];全国第二届中医中西医结合肾脏病临床进展学术研讨会论文集[C];2007年
4 张文铠;王志伏;王雪;孙大朋;;糖尿病肾病的治疗现状[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年
5 倪青;;糖尿病肾病的中西医结合研究[A];第六届全国中西医结合肾脏病学术会议论文汇编[C];2000年
6 孙怡;李健红;宗红燕;;黄芪桂枝五物汤加味治疗糖尿病肾病16例[A];第六届全国中西医结合肾脏病学术会议论文汇编[C];2000年
7 叶军;;糖尿病肾病在儿童时期的早期干预[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
8 杜旭昶;孙志红;闫春芳;刘彩虹;;疏糖丹治疗2型糖尿病50例临床分析[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
9 于世家;任平;马丽佳;李小娟;郑曙琴;武明东;刘自力;薛丽辉;;糖尿病住院患者1344例回顾性分析[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
10 郝效槐;魏玫都;崔立俊;;中西并蓄治疗糖尿病肾病[A];第七次中国中西医结合糖尿病学术会议论文汇编[C];2004年
相关重要报纸文章 前10条
1 本报记者 向佳;糖尿病中医药防治项目立足社区[N];中国中医药报;2011年
2 特约记者 鲁海燕;逾八成公众存在糖尿病高危因素[N];家庭医生报;2013年
3 马明愈;现代生活方式导致 糖尿病发病率迅速上升[N];中国妇女报;2005年
4 省立医院内分泌科主任医师 侯建明;糖尿病肾病的防治[N];福建科技报;2004年
5 王文绢 范军星;世界糖尿病日关注焦点:糖尿病并发症[N];健康报;2003年
6 主持人 向红丁博士;糖尿病肾病须早防早治[N];人民政协报;2002年
7 华悦;预防糖尿病,从减肥开始[N];上海中医药报;2004年
8 刘冬梅;肥胖糖尿病第一诱因[N];天津日报;2004年
9 刘燕玲;首部中医专病指南定下糖尿病治则[N];健康报;2007年
10 崔昕;中药防治糖尿病肾病有进展[N];健康时报;2006年
相关博士学位论文 前10条
1 王晓杰;组蛋白去乙酰化酶4特异性促进糖尿病肾病足细胞损伤[D];山东大学;2015年
2 张永;MiR-346在抗TGF-β信号途径介导的糖尿病肾病发生和发展中的作用机制[D];武汉大学;2015年
3 魏凤江;高尿酸血症、2型糖尿病及糖尿病微血管病变的群体遗传学研究[D];天津医科大学;2015年
4 孙士杰;胱抑素C对2型糖尿病视网膜病变预测价值研究[D];山东大学;2015年
5 魏艳红;PKCα介导的EGFR降解在糖尿病肾病足细胞损伤中的作用及机制[D];华中科技大学;2015年
6 龙泓竹;益气养阴通络散结方防治早期糖尿病肾病的临床及实验研究[D];北京中医药大学;2016年
7 姜e,
本文编号:1339225
本文链接:https://www.wllwen.com/yixuelunwen/nfm/1339225.html